Completed PHASE1 INTERVENTIONAL 3-arm
NCT07304921
Novel Approach to Increase EPA and DHA Levels
The Intake of Omega-3 Fatty Acids and the Inhibition of Their Mitochondrial Metabolism Increase EPA and DHA Levels in Healthy Volunteers
Sponsor: Riga Stradins University
Interventions
Meldonium + PUFA PUFA + meldonium PUFA supplementation only
Updated 1 time since 2026 Last updated: Dec 11, 2025 Started: Apr 6, 2023 Primary completion: Jun 6, 2023 Completion: Jun 6, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07304921, this PHASE1 trial focuses on Lipid Metabolism and Omega-3 Polyunsaturated Fatty Acids and remains completed. Sponsored by Riga Stradins University, it has been updated 1 time since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Completed — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Riga Stradins University
Data source: Riga Stradins University
For direct contact, visit the study record on ClinicalTrials.gov .